Vyome logo
Vyome
HIND | NASDAQ
Chart Builder DCF Calculator
$1.53
-$0.05 (-3.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.55
+$0.02 (+1.31%)
After-hours: Nov 16, 2026, 7:40 PM ET

Vyome Company Profile

Company profile explained

Company Profile

Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.

Key Executives

Name Position
Venkateswarlu Nelabhotla Co-Founder, Chief Executive Officer, President & Director
Richard Fahrner Chief Technology Officer
Robert Dickey Chief Financial Officer
Charles G. Chavdarian Senior Vice President of Product Development & Regulatory CMC
Jerry Leonard CFO, Principal Financial & Accounting Officer
Jules Abraham Investor Relations Officer
Shiladitya Sengupta Co-Founder, Director and Member of Scientific & Clinical Advisory Board
Tamara Agajanov Senior Vice President of Clinical Development

Latest SEC Filings

Date Type Title
Sep 03, 2026 4 Filing
Sep 01, 2026 3 Filing
Aug 28, 2026 8-K Current Report
Aug 25, 2026 8-K Current Report
Aug 12, 2026 10-Q Quarterly Report
May 29, 2026 8-K Current Report
May 12, 2026 10-Q Quarterly Report
Apr 29, 2026 8-K Current Report
Mar 31, 2026 DEF 14A Filing
Mar 20, 2026 PRE 14A Filing
View All SEC Filings ➞
Vyome
Vyome logo
Country United States
IPO Date Oct 6, 2016
Industry Biotechnology
Sector Healthcare
Employees 18
CEO Venkateswarlu Nelabhotla

Contact Details

Harvard Square Cambridge, Massachusetts 02138 United States

Stock Details

Ticker Symbol HIND
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001427570
CUSIP Number 92943X104
ISIN Number US92943X1046
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.